Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Moving towards the pan-European unification of Multiple Sclerosis Nurses: a consensus paper.
Effects of exercise on fitness and cognition in progressive MS: a randomized, controlled pilot trial.
Recurrence or rebound of clinical relapses after discontinuation of natalizumab therapy in highly active MS patients.
Frequent but nonspecific venous narrowing in paediatric multiple sclerosis.
Quantitative assessment of multiple sclerosis using inertial sensors and the TUG test.
Birth outcomes of pregnancies fathered by men with multiple sclerosis.
Abnormalities of Motor Imagery and Relationship With Depressive Symptoms in Mildly Disabling Relapsing-Remitting Multiple Sclerosis.
Active, phosphorylated fingolimod inhibits histone deacetylases and facilitates fear extinction memory.
QualiCOP: real-world effectiveness, tolerability, and quality of life in patients with relapsing-remitting multiple sclerosis treated with glatiramer acetate, treatment-naïve patients, and previously treated patients.
Natalizumab in pediatric multiple sclerosis: results of a cohort of 55 cases.
Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor-1 agonists induce ubiquitinylation and proteasomal degradation of the receptor.
Lipoatrophy in patients with multiple sclerosis on glatiramer acetate.
Long term follow up of peripheral lymphocyte subsets in a cohort of multiple sclerosis patients treated with natalizumab.
Cost-effectiveness of natalizumab vs fingolimod for the treatment of relapsing-remitting multiple sclerosis: analyses in Sweden.
Changes in phospholipid composition of the spinal cord in rabbits with allergic encephalomyelitis as an experimental model of multiple sclerosis.
JC-virus seroconversion in multiple sclerosis patients receiving natalizumab.
MARGA: Multispectral Adaptive Region Growing Algorithm for brain extraction on axial MRI.
The EDSS-Plus, an improved endpoint for disability progression in secondary progressive multiple sclerosis.
In vivo evidence of glutamate toxicity in multiple sclerosis.
Cytokine profile in relapsing‑remitting multiple sclerosis patients and the association between progression and activity of the disease.
Plasma exchange in severe attacks of neuromyelitis optica.
Gap junction pathology in multiple sclerosis lesions and normal-appearing white matter.
A qualitative exploration of the impact of a 12-week group exercise class for those moderately affected with multiple sclerosis.
Posterior reversible encephalopathy syndrome masquerading as progressive multifocal leukoencephalopathy in rituximab treated neuromyelitis optica.
Astrocytes Underlie Neuroinflammatory Memory Impairment.

Pages